Li Ju Yeh
Director/Board Member chez DELTA ASIA INTERNATIONAL CORPORATION
Profil
Li Ju Yeh is an Independent Director at Delta Asia International Corp.
and Tricorntech Corp.
She previously worked as Deputy Spokesman and Head of Finance & Accounting at TWi Pharmaceuticals, Inc. and as Assistant Deputy GM and Head of Finance & Accounting at TWi Biotechnology, Inc. Ms. Yeh is a graduate of National Sun Yat-Sen University.
Postes actifs de Li Ju Yeh
| Sociétés | Poste | Début |
|---|---|---|
| DELTA ASIA INTERNATIONAL CORPORATION | Director/Board Member | 12/11/2019 |
| TRICORNTECH TAIWAN CORPORATION | Director/Board Member | - |
Anciens postes connus de Li Ju Yeh
| Sociétés | Poste | Fin |
|---|---|---|
| TWI BIOTECHNOLOGY, INC. | Director of Finance/CFO | 01/09/2019 |
| TWI PHARMACEUTICALS INC | Director of Finance/CFO | - |
Formation de Li Ju Yeh
| National Sun Yat-Sen University | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| TWI BIOTECHNOLOGY, INC. | Health Technology |
| DELTA ASIA INTERNATIONAL CORPORATION | Health Technology |
| TRICORNTECH TAIWAN CORPORATION | Electronic Technology |
| Entreprise privées | 1 |
|---|---|
TWi Pharmaceuticals, Inc.
 TWi Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology TWi Pharmaceuticals, Inc. operates as a technology-based special pharmaceutical company. The firm engages in the development and commercialization of high barrier generics drugs. Its products include donepezil hydrochloride tablets, megestrol acetate oral suspension, hydroquinone cream, guanfacine extended-release tablets and nifedipine extended-release tablets. The company was founded by Chih Ming Chen on December 1, 1997 and is headquartered in Taipei, Taiwan. | Health Technology |
